USPTO serial 90123194

EVERGLADE PHARMACEUTICALS

Reg. 6435930Status 700Renewal

Need help with EVERGLADE PHARMACEUTICALS?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Deadline: July 27th, 2027

Class	Description	Status	First use
042	Pharmaceutical products development; Pharmaceutical research and development	ACTIVE	Aug 1, 2020
044	Pharmaceutical advice	ACTIVE	Aug 1, 2020

Date	Code	Event
Aug 21, 2026	ES8R	TEAS SECTION 8 RECEIVED
Jul 27, 2026	REM1	COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 18, 2023	TCCA	TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 18, 2023	CHAN	APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 18, 2023	COAR	TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 11, 2023	ASGN	AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 27, 2021	R.PR	REGISTERED-PRINCIPAL REGISTER
Jun 22, 2021	SUNA	NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 21, 2021	CNPR	ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 12, 2021	SUPC	STATEMENT OF USE PROCESSING COMPLETE
May 12, 2021	AITU	CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 28, 2021	IUAF	USE AMENDMENT FILED
Apr 28, 2021	EISU	TEAS STATEMENT OF USE RECEIVED
Mar 16, 2021	NOAM	NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 19, 2021	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 19, 2021	PUBO	PUBLISHED FOR OPPOSITION
Dec 30, 2020	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 16, 2020	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 16, 2020	DOCK	ASSIGNED TO EXAMINER
Sep 22, 2020	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 22, 2020	NWAP	NEW APPLICATION ENTERED